• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析降低血浆中的阿尔茨海默病淀粉样-β及其与认知功能的关系。

Reduction of Alzheimer's disease amyloid-β in plasma by hemodialysis and its relation to cognitive functions.

机构信息

Faculty of Clinical Engineering Technology, School of Health Sciences, Fujita Health University, Kutsukake-cho, Toyoake, Japan.

出版信息

Blood Purif. 2011;32(1):57-62. doi: 10.1159/000322624. Epub 2011 Feb 24.

DOI:10.1159/000322624
PMID:21346337
Abstract

BACKGROUND/AIMS: Rapid removal of plasma amyloid-β (Aβ) by blood purification may serve as a peripheral Aβ sink from the brain for Alzheimer's disease therapy. We investigated the reduction of plasma Aβ during hemodialysis and cognitive states.

METHODS

Aβ concentrations and Mini-Mental State Examinations (MMSE) were investigated in 37 hemodialysis patients (68.9 ± 4.1 years).

RESULTS

The dialyzers effectively removed Aβ(1-40) and Aβ(1-42), 63.9 ± 14.4 and 51.6 ± 17.0% at 4 h dialysis, resulting in the reduction of Aβs in whole-body circulation by 51.1 ± 8.9 and 32.7 ± 12.0%, respectively. Although the plasma Aβs before dialysis (750.8 ± 171.3 pg/ml for Aβ(1-40)) were higher than those reported for Alzheimer's disease patients, the cognitive states of hemodialysis patients were relatively normal, especially of longer dialysis vintages.

CONCLUSIONS

Dialyzers effectively reduced Aβs in whole-body circulation. Repeated rapid decrease of plasma Aβs might maintain cognitive state.

摘要

背景/目的:通过血液净化快速清除血浆中的淀粉样蛋白-β(Aβ)可能成为阿尔茨海默病治疗中大脑的外周 Aβ清除途径。我们研究了血液透析过程中 Aβ 的减少及其与认知状态的关系。

方法

我们对 37 名血液透析患者(68.9±4.1 岁)进行了 Aβ 浓度和简易精神状态检查(MMSE)的检测。

结果

4 小时透析时,透析器有效去除 Aβ(1-40)和 Aβ(1-42),分别为 63.9±14.4%和 51.6±17.0%,导致全身循环中的 Aβ 减少 51.1±8.9%和 32.7±12.0%。尽管血液透析患者的血浆 Aβ 水平(Aβ(1-40)为 750.8±171.3 pg/ml)高于阿尔茨海默病患者的报道,但他们的认知状态相对正常,特别是透析时间较长的患者。

结论

透析器可有效降低全身循环中的 Aβ 水平。反复快速降低血浆 Aβ 水平可能有助于维持认知状态。

相似文献

1
Reduction of Alzheimer's disease amyloid-β in plasma by hemodialysis and its relation to cognitive functions.血液透析降低血浆中的阿尔茨海默病淀粉样-β及其与认知功能的关系。
Blood Purif. 2011;32(1):57-62. doi: 10.1159/000322624. Epub 2011 Feb 24.
2
Potential therapeutic system for Alzheimer's disease: removal of blood Aβs by hemodialzyers and its effect on the cognitive functions of renal-failure patients.阿尔茨海默病的潜在治疗系统:通过血液透析器清除血液 Aβs 及其对肾衰竭患者认知功能的影响。
J Neural Transm (Vienna). 2012 Dec;119(12):1533-44. doi: 10.1007/s00702-012-0844-5. Epub 2012 Jun 15.
3
A prospective study on blood Aβ levels and the cognitive function of patients with hemodialysis: a potential therapeutic strategy for Alzheimer's disease.血液Aβ水平与血液透析患者认知功能的前瞻性研究:阿尔茨海默病的潜在治疗策略
J Neural Transm (Vienna). 2015 Nov;122(11):1593-607. doi: 10.1007/s00702-015-1431-3. Epub 2015 Jul 31.
4
Adsorptive filtration systems for effective removal of blood amyloid β: a potential therapy for Alzheimer's disease.用于有效去除血液中β淀粉样蛋白的吸附过滤系统:一种治疗阿尔茨海默病的潜在疗法。
J Artif Organs. 2018 Jun;21(2):220-229. doi: 10.1007/s10047-017-1012-3. Epub 2017 Dec 11.
5
Influx of Tau and Amyloid-β Proteins into the Blood During Hemodialysis as a Therapeutic Extracorporeal Blood Amyloid-β Removal System for Alzheimer's Disease.血液透析过程中 Tau 蛋白和淀粉样β蛋白流入血液作为阿尔茨海默病的一种治疗性体外血液淀粉样β清除系统
J Alzheimers Dis. 2019;69(3):687-707. doi: 10.3233/JAD-190087.
6
Reduction of Amyloid-β Plasma Levels by Hemodialysis: An Anti-Amyloid Treatment Strategy?血液透析降低血浆β淀粉样蛋白水平:一种抗淀粉样变治疗策略?
J Alzheimers Dis. 2016;50(3):791-6. doi: 10.3233/JAD-150662.
7
Serum beta-amyloid correlates with neuropsychological impairment.血清β-淀粉样蛋白与神经心理损害相关。
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2009 Mar;16(2):203-18. doi: 10.1080/13825580802411766.
8
Plasma biomarkers of Alzheimer's disease.阿尔茨海默病的血浆生物标志物
Curr Opin Psychiatry. 2008 May;21(3):260-7. doi: 10.1097/YCO.0b013e3282fc989f.
9
Plasma amyloid-beta forms in Alzheimer's disease and non-Alzheimer's disease patients.阿尔茨海默病患者和非阿尔茨海默病患者的血浆淀粉样蛋白-β形成。
J Alzheimers Dis. 2010;21(1):291-301. doi: 10.3233/JAD-2010-091501.
10
BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology.脑脊髓液中的 BACE1 活性及其与 AD 病理标志物的关系。
J Alzheimers Dis. 2010;20(1):253-60. doi: 10.3233/JAD-2010-1367.

引用本文的文献

1
Amyloid-beta metabolism in age-related neurocardiovascular diseases.年龄相关性神经心血管疾病中的β-淀粉样蛋白代谢
Eur Heart J. 2025 Jan 16;46(3):250-272. doi: 10.1093/eurheartj/ehae655.
2
Alzheimer Disease-Related Biomarkers in Patients on Maintenance Hemodialysis.维持性血液透析患者中与阿尔茨海默病相关的生物标志物
Kidney Med. 2024 Aug 28;6(11):100897. doi: 10.1016/j.xkme.2024.100897. eCollection 2024 Nov.
3
Aβ Influx into the Blood Evoked by Different Blood Aβ Removal Systems: A Potential Therapy for Alzheimer's Disease.不同血液Aβ清除系统诱发Aβ流入血液:一种治疗阿尔茨海默病的潜在疗法。
Neuropsychiatr Dis Treat. 2021 Jul 13;17:2291-2308. doi: 10.2147/NDT.S317104. eCollection 2021.
4
Renal Contributions in the Pathophysiology and Neuropathological Substrates Shared by Chronic Kidney Disease and Alzheimer's Disease.慢性肾脏病与阿尔茨海默病共有的病理生理学和神经病理学基础中的肾脏作用
Brain Sci. 2020 Aug 17;10(8):563. doi: 10.3390/brainsci10080563.
5
Immunoadsorption for Treatment of Patients with Suspected Alzheimer Dementia and Agonistic Autoantibodies against Alpha1a-Adrenoceptor-Rationale and Design of the IMAD Pilot Study.免疫吸附治疗疑似阿尔茨海默病痴呆且存在抗α1a-肾上腺素能受体激动性自身抗体的患者——IMAD初步研究的原理与设计
J Clin Med. 2020 Jun 19;9(6):1919. doi: 10.3390/jcm9061919.
6
Removal of Aβ Oligomers from the Blood: A Potential Therapeutic System for Alzheimer's Disease.从血液中清除β淀粉样蛋白寡聚体:一种治疗阿尔茨海默病的潜在治疗系统。
Neuropsychiatr Dis Treat. 2020 Mar 3;16:607-627. doi: 10.2147/NDT.S241074. eCollection 2020.
7
Removal of blood amyloid-β with hemodialysis reduced brain amyloid-β, confirmed by brain imaging: a case report.血液透析清除血液淀粉样蛋白-β可减少脑淀粉样蛋白-β,脑成像证实:病例报告
Neuropsychiatr Dis Treat. 2018 Nov 1;14:2931-2937. doi: 10.2147/NDT.S186118. eCollection 2018.
8
Adsorptive filtration systems for effective removal of blood amyloid β: a potential therapy for Alzheimer's disease.用于有效去除血液中β淀粉样蛋白的吸附过滤系统:一种治疗阿尔茨海默病的潜在疗法。
J Artif Organs. 2018 Jun;21(2):220-229. doi: 10.1007/s10047-017-1012-3. Epub 2017 Dec 11.
9
Toward the treatment for Alzheimer's disease: adsorption is primary mechanism of removing amyloid β protein with hollow-fiber dialyzers of the suitable materials, polysulfone and polymethyl methacrylate.迈向阿尔茨海默病的治疗:采用合适材料(聚砜和聚甲基丙烯酸甲酯)的中空纤维透析器去除β淀粉样蛋白的主要机制是吸附。
J Artif Organs. 2016 Jun;19(2):149-58. doi: 10.1007/s10047-015-0878-1. Epub 2015 Dec 19.
10
A prospective study on blood Aβ levels and the cognitive function of patients with hemodialysis: a potential therapeutic strategy for Alzheimer's disease.血液Aβ水平与血液透析患者认知功能的前瞻性研究:阿尔茨海默病的潜在治疗策略
J Neural Transm (Vienna). 2015 Nov;122(11):1593-607. doi: 10.1007/s00702-015-1431-3. Epub 2015 Jul 31.